Thermo Fisher Scientific Inc.  

(Public, NYSE:TMO)   Watch this stock  
Find more results for TMO
-0.61 (-0.39%)
Mar 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 153.69 - 155.67
52 week 137.70 - 161.66
Open 154.43
Vol / Avg. 1.94M/1.47M
Mkt cap 59.64B
P/E 30.22
Div/yield 0.15/0.39
EPS 5.10
Shares 390.39M
Beta 1.08
Inst. own 90%
Jan 26, 2017
Q4 2016 Thermo Fisher Scientific Inc Earnings Release (Estimated)
Jan 10, 2017
Thermo Fisher Scientific Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 12.77% 11.08%
Operating margin 15.19% 13.40%
EBITD margin - 25.19%
Return on average assets 5.40% 4.67%
Return on average equity 11.75% 9.44%
Employees 55,000 -
CDP Score - 77 D


168 3rd Ave
WALTHAM, MA 02451-7551
United States - Map
+1-781-6221000 (Phone)
+1-781-6221207 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.

Officers and directors

Jim P. Manzi Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Marc N. Casper President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen Williamson Chief Financial Officer, Senior Vice President
Age: 49
Bio & Compensation  - Reuters
Peter M. Wilver Executive Vice President, Chief Administrative Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark P. Stevenson Executive Vice President, President, Life Sciences Solutions
Age: 53
Bio & Compensation  - Reuters
Seth H. Hoogasian Senior Vice President, General Counsel, Secretary
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Patrick M. Durbin Senior Vice President, President - Specialty Diagnostics
Age: 49
Bio & Compensation  - Reuters
Thomas W. Loewald Senior Vice President, Chief Commercial Officer
Age: 52
Bio & Compensation  - Reuters
Daniel P. Shine Senior Vice President, President, Analytical Instruments
Age: 47
Bio & Compensation  - Reuters
Peter E. Hornstra Vice President, Chief Accounting Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance